Sharescart Research Club logo

Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹19550 Cr.
Stock P/E
34.4
P/B
6.6
Current Price
₹4350.1
Book Value
₹ 659.9
Face Value
10
52W High
₹6540
52W Low
₹ 4276.9
Dividend Yield
3.45%

Bayer CropScience Overview

Business

Bayer CropScience Ltd. is a leading player in the Indian agricultural sector, operating as a subsidiary of the global life sciences company Bayer AG. The company is primarily engaged in the business of crop protection, seeds, and digital farming solutions. It develops, produces, and markets a wide range of products including herbicides, fungicides, insecticides, and high-quality seeds for various crops. Its core business model revolves around providing integrated agricultural solutions to farmers, helping them improve crop yields, quality, and farm profitability. The company generates revenue through the sale of its crop protection products, hybrid seeds, and related agricultural advisory services.

Revenue Mix

Bayer CropScience Ltd.'s primary business can be broadly categorized into:

Crop Protection: This is the dominant segment and includes the sale of herbicides, insecticides, and fungicides designed to protect crops from weeds, pests, and diseases. This segment typically accounts for the majority of the company's revenue.

Seeds: This segment focuses on the development, production, and sale of high-yielding hybrid seeds for various crops such as corn, rice, cotton, and vegetables.

Environmental Science & Digital Farming: While smaller in comparison, this segment includes solutions for non-agricultural pest control and emerging digital tools for precision agriculture.

Exact revenue contributions for each segment are typically detailed in the company's annual financial reports, but Crop Protection consistently forms the largest share.

Industry

The Indian Pesticides & Agrochemicals industry is diverse, competitive, and heavily influenced by monsoon patterns, agricultural policies, and farmer income. It includes global multinational corporations (MNCs) and a large number of domestic players. Bayer CropScience is positioned as one of the leading players in the premium and innovative segment of the market. Leveraging the global R&D and technological prowess of its parent company, Bayer AG, it focuses on offering advanced, often patented, solutions. It competes with other global giants like Syngenta, BASF, Corteva, as well as strong domestic companies such as UPL, PI Industries, and Rallis India.

MOAT

Global R&D and Innovation: As part of Bayer AG, the company benefits from a massive global R&D pipeline, leading to the introduction of novel and often patented crop protection technologies and advanced seed varieties. This allows it to offer differentiated products.

Brand Recognition & Trust: Bayer is a globally recognized and trusted brand among farmers, built on decades of product efficacy and reliability.

Extensive Distribution Network: A well-established and wide-reaching distribution network across India ensures product availability even in remote agricultural regions.

Comprehensive Portfolio: A broad and diverse portfolio of crop protection products and seeds for various crops and geographies provides a strong market presence.

Growth Drivers

Increasing Food Demand: Growing population and rising incomes in India drive the need for higher agricultural productivity and quality produce.

Adoption of Advanced Technologies: Farmers' increasing awareness and willingness to adopt advanced crop protection solutions and high-yielding seeds to enhance productivity and mitigate risks.

Digital Farming Solutions: The nascent but growing adoption of precision agriculture, data analytics, and digital tools for optimized farm management.

Crop Diversification & Intensification: Changing cropping patterns and the need for specialized solutions for diverse crops.

Government Support: Favorable government policies for agriculture, including irrigation projects, credit facilities, and minimum support prices, can boost farmer purchasing power.

Risks

Monsoon Dependency: Indian agriculture is highly reliant on the monsoon. Erratic or insufficient rainfall can significantly impact crop yields, farmer income, and demand for agrochemicals.

Regulatory Environment: Strict and evolving government regulations regarding product approvals, environmental impact, pricing controls, and bans on certain chemicals pose operational risks.

Commodity Price Volatility: Fluctuations in agricultural commodity prices directly affect farmer profitability and their ability to invest in high-value inputs.

Pest Resistance: Continuous evolution of pest and disease resistance requires constant R&D and product innovation, incurring significant costs.

Counterfeit Products: The market faces challenges from the proliferation of spurious and counterfeit agrochemical products, impacting legitimate sales and farmer trust.

Environmental Scrutiny: Increasing global and local environmental concerns over chemical use in agriculture could lead to stricter norms or product restrictions.

Management & Ownership

Bayer CropScience Ltd. is majority-owned by Bayer AG, a German multinational pharmaceutical and life sciences company. The promoter holding typically exceeds 70%. The company benefits from a professional management team, drawing upon global expertise, research capabilities, and best practices from its parent organization. The management quality is generally perceived as strong, with a focus on sustainable agricultural practices and ethical operations.

Outlook

Bayer CropScience Ltd. is well-positioned in the growing Indian agricultural market, leveraging its strong global parentage, robust R&D capabilities, and extensive product portfolio. The increasing demand for food, need for higher yields, and adoption of modern farming practices present significant growth opportunities. However, the company operates in a highly cyclical industry heavily dependent on monsoon patterns, prone to regulatory shifts, and intense competition from both MNCs and domestic players. Its ability to continuously innovate, navigate regulatory complexities, and effectively manage its supply chain amidst volatile raw material prices will be crucial for sustained performance. The focus on sustainable solutions and digital farming could provide a long-term edge.

Bayer CropScience Share Price

Live · BSE / NSE · Inception: 1958
| |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

Bayer CropScience Quarterly Results

#(Fig in Cr.) Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 955 792 1631 1738 1057 1046 1915 1553 1106 1101
Other Income 15 29 27 23 32 37 19 14 16 47
Total Income 970 821 1659 1761 1090 1084 1933 1567 1122 1147
Total Expenditure 827 695 1317 1554 1037 876 1566 1348 989 898
Operating Profit 143 126 342 208 52 208 367 219 133 250
Interest 3 5 4 3 4 6 5 4 5 6
Depreciation 15 16 22 14 15 34 27 14 15 38
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 124 105 316 190 34 168 335 200 113 206
Provision for Tax 31 9 62 54 -1 25 57 48 17 44
Profit After Tax 93 96 254 136 34 143 279 153 96 162
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 93 96 254 136 34 143 279 153 96 162
Adjusted Earnings Per Share 20.7 21.4 56.6 30.4 7.6 31.9 62.1 34 21.3 36.1

Bayer CropScience Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 3723 2769 2803 2710 3167 3609 4261 4734 5140 5106 5473 5675
Other Income 91 82 72 39 53 67 66 60 73 81 121 96
Total Income 3814 2851 2874 2749 3221 3676 4327 4794 5213 5187 5595 5769
Total Expenditure 3211 2335 2391 2301 2687 2884 3452 3929 4225 4152 4785 4801
Operating Profit 603 516 484 448 534 792 876 866 988 1035 809 969
Interest 5 10 7 11 10 14 13 13 22 20 17 20
Depreciation 25 25 29 33 44 65 74 65 80 74 85 94
Exceptional Income / Expenses 0 0 0 0 0 -130 5 59 104 0 0 0
Profit Before Tax 574 482 448 404 480 583 795 847 990 941 707 854
Provision for Tax 191 167 157 104 143 109 301 202 232 201 139 166
Profit After Tax 383 315 291 300 337 475 493 645 758 741 568 690
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 383 315 291 300 337 475 493 645 758 741 568 690
Adjusted Earnings Per Share 104.6 89 82.2 87.5 98.3 105.7 109.8 143.7 168.9 164.9 126.5 153.5

Bayer CropScience Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 2033 1839 2057 1778 2239 2573 2550 2524 2712 2849 2850
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 1155 1359 1539 1502 1614 1590 1783 2365 2792 2952 3117
Total Current Liabilities 856 538 829 950 1684 1765 2273 2073 1995 1815 2441
Total Liabilities 4044 3737 4425 4230 5537 5928 6607 6962 7500 7616 8408
Fixed Assets 322 290 311 304 409 438 395 441 437 389 445
Other Non-Current Assets 1175 1409 1594 1562 1852 1850 1965 2531 2949 3104 3274
Total Current Assets 2548 2037 2520 2364 3271 3640 4247 3989 4114 4123 4689
Total Assets 4044 3737 4425 4230 5537 5928 6607 6962 7500 7616 8408

Bayer CropScience Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 486 1130 762 838 417 578 1067 1205 781 861 1157
Cash Flow from Operating Activities 200 207 157 121 433 666 687 216 609 952 262
Cash Flow from Investing Activities 485 16 -8 38 -415 -29 7 64 83 0 86
Cash Flow from Financing Activities -42 -590 -73 -581 -158 -148 -556 -703 -613 -656 -619
Net Cash Inflow / Outflow 644 -367 76 -421 -140 489 138 -424 79 296 -272
Closing Cash & Cash Equivalent 1130 762 838 417 578 1067 1205 781 860 1157 885

Bayer CropScience Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 104.64 89.01 82.2 87.49 98.28 105.68 109.82 143.72 168.86 164.92 126.5
CEPS(Rs) 111.56 95.99 90.37 97.14 111.05 120.22 126.19 158.08 186.57 181.4 145.41
DPS(Rs) 21 17 17 18 18 25 115 150 130 140 125
Book NAV/Share(Rs) 555.44 519.6 580.99 518.45 649.8 572.94 568 562.2 604.03 634.61 634.83
Core EBITDA Margin(%) 13.13 15.02 13.98 14.88 13.7 17.66 16.75 14.78 15.51 15.54 10.95
EBIT Margin(%) 14.81 17.01 15.43 15.1 13.97 14.53 16.7 15.77 17.16 15.66 11.53
Pre Tax Margin(%) 14.69 16.67 15.19 14.69 13.68 14.19 16.44 15.53 16.78 15.34 11.26
PAT Margin (%) 9.81 10.91 9.87 10.92 9.6 11.55 10.2 11.84 12.85 12.07 9.04
Cash Profit Margin (%) 10.46 11.76 10.85 12.12 10.85 13.14 11.72 13.02 14.2 13.27 10.39
ROA(%) 10.21 8.1 7.13 6.93 6.9 8.28 7.87 9.51 10.49 9.8 7.09
ROE(%) 20.29 16.27 14.94 15.65 16.83 19.77 19.25 25.43 28.96 26.63 19.93
ROCE(%) 30.63 25.39 23.35 21.65 24.41 24.8 31.5 33.88 38.67 34.56 25.42
Receivable days 45.87 61.65 59.51 80.68 70.58 62.93 55.61 58.91 61.25 57.56 55.55
Inventory Days 52.1 77.64 88.68 100.11 98.63 94.2 86.4 94.98 102.67 99.69 113.49
Payable days 42.41 60.13 57.04 67.53 107.39 112.12 102.62 118.74 114.74 97.05 95.91
PER(x) 31.78 42.34 46.15 48.04 44.61 32.73 48.31 34.67 23.97 31.79 38.95
Price/Book(x) 5.99 7.25 6.53 8.11 6.75 6.04 9.34 8.86 6.7 8.26 7.76
Dividend Yield(%) 0.63 0.45 0.45 0.43 0.41 0.72 2.17 3.01 3.21 2.67 2.54
EV/Net Sales(x) 2.97 4.54 4.49 5.17 4.56 4.01 5.31 4.56 3.37 4.38 3.88
EV/Core EBITDA(x) 18.3 24.36 26.03 31.23 27.06 18.25 25.83 24.93 17.52 21.62 26.23
Net Sales Growth(%) 14.73 -25.63 1.22 -3.31 16.88 13.96 18.06 11.1 8.56 -0.65 7.19
EBIT Growth(%) 29.74 -14.96 -7.49 -8.73 18.14 21.72 35.22 6.52 17.76 -5.08 -24.62
PAT Growth(%) 32.3 -17.73 -7.65 3.13 12.33 40.76 3.92 30.87 17.5 -2.33 -23.3
EPS Growth(%) 32.3 -14.94 -7.65 6.43 12.33 7.53 3.92 30.87 17.5 -2.33 -23.3
Debt/Equity(x) 0 0 0 0 0 0 0 0 0 0 0
Current Ratio(x) 2.98 3.79 3.04 2.49 1.94 2.06 1.87 1.92 2.06 2.27 1.92
Quick Ratio(x) 2.32 2.55 2.11 1.71 1.26 1.52 1.29 1.19 1.16 1.42 0.95
Interest Cover(x) 125.67 49.16 65.91 36.73 47.15 43.25 64.06 66.64 45.4 49.03 42.61
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +7% +5% +9% +4%
Operating Profit CAGR -22% -2% 0% +3%
PAT CAGR -23% -4% +4% +4%
Share Price CAGR -22% 0% -4% +1%
ROE Average +20% +25% +24% +20%
ROCE Average +25% +33% +33% +29%

Bayer CropScience Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 71.43 %
FII 3.89 %
DII (MF + Insurance) 11.89 %
Public (retail) 28.57 %
# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 71.4371.4371.4371.4371.4371.4371.4371.4371.4371.43
FII 3.543.623.633.33.423.493.643.793.843.89
DII 12.712.812.4712.0811.711.5511.3811.2111.4611.89
Public 28.5728.5728.5728.5728.5728.5728.5728.5728.5728.57
Others 0000000000
Total 100100100100100100100100100100

Bayer CropScience Peer Comparison

Pesticides & Agrochemicals Edit Columns

Bayer CropScience Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Bayer CropScience Pros & Cons

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 25%
  • Debtor days have improved from 97.05 to 95.91days.
  • Company is almost debt free.

Cons

  • Stock is trading at 6.6 times its book value.
  • The company has delivered a poor profit growth of 3% over past five years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp